# Multiple Ascending Dose Study of MHS552 in Adults With Type 1 Diabetes Mellitus

> **NCT05272059** · PHASE1 · WITHDRAWN · sponsor: **Novartis Pharmaceuticals**

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** MHS552
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05272059
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-09-01
- **Primary completion:** 2025-04-14
- **Final completion:** 2025-04-14
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2023-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05272059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05272059, "Multiple Ascending Dose Study of MHS552 in Adults With Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT05272059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*